Showing 1 - 6 results of 6 for search 'Derek J. Erstad', query time: 0.03s Refine Results
  1. 1
    The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer

    The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer by Derek J. Erstad, Andrew M. Tager, Yujin Hoshida, Bryan C. Fuchs

    Published 2017-05-01
    Get full text
    Article
  2. 2
    Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma

    Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma by Raymond S. Traweek, Brandon M. Cope, Christina L. Roland, Emily Z. Keung, Elise F. Nassif, Derek J. Erstad

    Published 2022-11-01
    Get full text
    Article
  3. 3
    Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

    Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram by Gong Zhang, Gong Zhang, Yufeng Wang, Yufeng Wang, Bryan C. Fuchs, Wei Guo, David L. Drum, Derek J. Erstad, Baomin Shi, Albert B. DeLeo, Hui Zheng, Lei Cai, Liyuan Zhang, Kenneth K. Tanabe, Xinhui Wang

    Published 2022-07-01
    Get full text
    Article
  4. 4
    An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

    An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective by Hexiao Tang, MD, PhD, Eric Abston, MD, PhD, Mozhdeh Sojoodi, PhD, Yongtao Wang, PhD, Derek J. Erstad, MD, Zenan Lin, MD, Bryan C. Fuchs, PhD, Kenneth K. Tanabe, MD, Michael Lanuti, MD

    Published 2024-04-01
    Get full text
    Article
  5. 5
    Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverSummary

    Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverSummary by Mozhdeh Sojoodi, Derek J. Erstad, Stephen C. Barrett, Shadi Salloum, Shijia Zhu, Tongqi Qian, Selene Colon, Eric M. Gale, Veronica Clavijo Jordan, Yongtao Wang, Shen Li, Bahar Ataeinia, Sasan Jalilifiroozinezhad, Michael Lanuti, Lawrence Zukerberg, Peter Caravan, Yujin Hoshida, Raymond T. Chung, Gautam Bhave, Georg M. Lauer, Bryan C. Fuchs, Kenneth K. Tanabe

    Published 2022-01-01
    Get full text
    Article
  6. 6
    Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist

    Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist by Derek J. Erstad, Christian T. Farrar, Sarani Ghoshal, Ricard Masia, Diego S. Ferreira, Yin‐Ching Iris Chen, Ji‐Kyung Choi, Lan Wei, Phillip A. Waghorn, Nicholas J. Rotile, Chuantao Tu, Katherine A. Graham‐O'Regan, Mozhdeh Sojoodi, Shen Li, Yang Li, Guogiang Wang, Kathleen E. Corey, Yat Sun Or, Lijuan Jiang, Kenneth K. Tanabe, Peter Caravan, Bryan C. Fuchs

    Published 2018-07-01
    Get full text
    Article

Search Tools: